Pregnancy and Multiple Sclerosis Treatment Safety
Reviews Pregnancy and Multiple Sclerosis Treatment Safety and highlights the practical decisions that shape diagnosis, treatment, and follow-up.
Duration
00:03:12
File size
1.90 MB
Practitioner-Guided Note
Use Pregnancy and Multiple Sclerosis Treatment Safety to guide the working diagnosis and next step; let the main risk or management issue drive escalation, treatment choice, and follow-up.
Key Takeaways
Teriflunomide requires a very specific, accelerated elimination procedure using cholestyramine to physically flush the drug out of the system safely.; Catching the actual influenza virus poses a major threat because systemic infections significantly drive up the risk of a multiple sclerosis relapse.; Though, studies show that going through a pregnancy does not negatively impact an individual's long-term disability outcome.; Natalizumab is a unique case because stopping it completely can trigger a severe, dangerous rebound of disease activity.; Other advanced agents, however, carry far stricter warnings due to documented risks of fetal toxicity or clear teratogenic potential.